Chromadex Corporation (CDXC) Swing to Q1 Profit
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Nasdaq futures drop over 2% on concerns over AI buildout costs, Fed rate outlook
- Nasdaq 100 set to shed over $1 trillion as tech selloff deepens; SpaceX slides
- Oil steady as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Spain's ex-transport minister sentenced to 24 years for corruption
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
ChromaDex Reports Record Revenue and Quarterly Net Income as Ingredients Sales Climb 72%
May 12, 2016 6:30 AM EDT-Company Records Net Income of $256,000 as Company Reports Record Revenue of $7.3 Million-
IRVINE, Calif., May 12, 2016 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ: CDXC), an innovator of proprietary health, wellness, and nutritional ingredients, that creates science-based solutions for dietary supplement, food and beverage, skin care, sports nutrition, and pharmaceutical products, announced today record revenue for the first quarter ended April 2, 2016.Â
Results of operations for the three months ended April 2, 2016
For the three months ended April 2, 2016 (Q1 2016), ChromaDex reported record net sales... More
